LAUREN FENNER: Open Payments
NPI 1346908019 · SHARPSBURG, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 16 payments from 7 companies in 2025. Trend: 2023 $19 · 2024 $303 · 2025 $316
Food & beverage: $316
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $103 |
| Lilly USA, LLC | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| Dexcom, Inc. | 2 | $43 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| ABBVIE INC. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
Products named: Dexcom G6 Transmitter, Rybelsus, MOUNJARO, GEMTESA, Ozempic, BREZTRI, Wegovy, JARDIANCE.
Industry payments across GA — which companies pay providers there.
